Statistics for Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer
Total visits
views | |
---|---|
Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer | 93 |
Total visits per month
views | |
---|---|
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:17c73ff2-d3fd-4172-aee7-a3ee0e53a19b | 50 |
41523_2021_Article_240.pdf | 49 |
java.util.UUID:6d97f45a-b1b2-4697-abf2-f0dfa3aaf72c | 25 |
java.util.UUID:f9a993e1-6935-42e1-b019-ea80c89d34ec | 8 |
Top country views
views | |
---|---|
United States | 80 |
China | 1 |
South Korea | 1 |
Malaysia | 1 |
Sweden | 1 |
Slovenia | 1 |
Top city views
views | |
---|---|
Wilmington | 42 |
Houston | 11 |
White Plains | 9 |
Fairfield | 4 |
Indianapolis | 2 |
Ann Arbor | 1 |
Baltimore | 1 |
Beijing | 1 |
Cambridge | 1 |
Falls Church | 1 |
Kuala Lumpur | 1 |
Ljubljana | 1 |
San Francisco | 1 |
Seoul | 1 |
Umeå | 1 |
Washington | 1 |